|
Sponsors, CROs Shy Away From India's Regulatory Stalemate
India’s drugs regulatory agency, largely nonfunctional over the last year, is causing some drug developers to pull back from conducting clinical trials in the country, John Lewis, the Association of Clinical Research Organizations (ACRO) vice president of public affairs, tells CTA.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives